10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001213900-13-006399`
Period End Date	20130930
Filing Date	20131114
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	gldsw-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 23 Cash Flow Statement 58 Stockholders Equity 29

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	4,000.00	shares	Point-in-time
Cash	`Cash`	$279.00	USD	Point-in-time
Cash	`Cash`	$1.26M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.26M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$279.00	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	4,000.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$279.00	USD	Point-in-time
Total Assets	`Assets`	$1.26M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.23M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$9.95K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.23M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69K	USD	Point-in-time
Accrued Offering Costs	`AccruedOfferingCosts`	$10.00K	USD	Point-in-time
Accrued Offering Costs	`AccruedOfferingCosts`	-	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$20.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$5.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	-	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	$1.64K	USD	Point-in-time
Common stock payable	`CommonStockPayable`	-	USD	Point-in-time
Common stock payable	`CommonStockPayable`	$673.89K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$715.48K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$25.69K	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$15.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrentAndNoncurrent`	$782.00	USD	Point-in-time
Interest payable	`InterestPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$15.78K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$41.47K	USD	Point-in-time
Total Liabilities	`Liabilities`	$715.48K	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 4,000 and none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 4,000 and none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 36,231,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 36,231,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.62K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.86M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.22M	USD	Point-in-time
Subscription receivable	`CommonStockShareSubscribedButUnissuedSubscriptionsReceivable`	$100.00K	USD	Point-in-time
Subscription receivable	`CommonStockShareSubscribedButUnissuedSubscriptionsReceivable`	$100.00K	USD	Point-in-time
Subscription receivable	`CommonStockShareSubscribedButUnissuedSubscriptionsReceivable`	-	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$47.48K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$543.62K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.26M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$279.00	USD	Point-in-time

Income Statement 23 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$27.26K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.74K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$51.10K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.22M	USD	13 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-51.10K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.26K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.22M	USD	13 Qtrs
Net loss	`NetIncomeLoss`	$-8.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	13 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.73M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	3 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.70M	shares	3 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.51M	shares	13 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-51.10K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.26K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.22M	USD	13 Qtrs
Net loss	`NetIncomeLoss`	$-8.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Stock issued for services - related parties	`ShareBasedCompensation`	$1.07M	USD	13 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	3 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	3 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$11.59K	USD	13 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$10.78K	USD	3 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-9.88K	USD	3 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-60.98K	USD	3 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-132.26K	USD	13 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.47K	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	13 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from issuance of Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$400.00K	USD	3 Qtrs
Proceeds from issuance of Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	3 Qtrs
Proceeds from issuance of Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$400.00K	USD	13 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.07M	USD	13 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.02M	USD	3 Qtrs
Payment For Direct Offering Costs	`PaymentForDirectOfferingCostsInCash`	$100.19K	USD	13 Qtrs
Payment For Direct Offering Costs	`PaymentForDirectOfferingCostsInCash`	-	USD	3 Qtrs
Payment For Direct Offering Costs	`PaymentForDirectOfferingCostsInCash`	$100.19K	USD	3 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.39M	USD	13 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$15.00K	USD	3 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.32M	USD	3 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.26M	USD	13 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.47K	USD	3 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.26M	USD	3 Qtrs
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.26M	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Payment of taxes	`IncomeTaxesPaid`	-	USD	13 Qtrs
Payment of taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Payment of taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Payment of interest	`InterestPaid`	-	USD	3 Qtrs
Payment of interest	`InterestPaid`	-	USD	3 Qtrs
Payment of interest	`InterestPaid`	-	USD	13 Qtrs
Accrued direct offering costs	`PaymentForDirectOfferingCosts`	$10.00K	USD	Point-in-time
Accrued direct offering costs	`PaymentForDirectOfferingCosts`	$-10.00K	USD	3 Qtrs
Accrued direct offering costs	`PaymentForDirectOfferingCosts`	-	USD	3 Qtrs
Accrued direct offering costs	`PaymentForDirectOfferingCosts`	$-10.00K	USD	13 Qtrs
Subscriptions receivable	`StockIssuedToRelatedPartiesInConnectionWithSubscriptionReceivable`	-	USD	3 Qtrs
Subscriptions receivable	`StockIssuedToRelatedPartiesInConnectionWithSubscriptionReceivable`	$-100.00K	USD	3 Qtrs
Subscriptions receivable	`StockIssuedToRelatedPartiesInConnectionWithSubscriptionReceivable`	$-100.00K	USD	13 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Stock issued for services - related parties, Value per share	`StockIssuedForServicesRelatedPartiesFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, Value per share	`StockIssuedForCashFairMarketValue`	$0.20	USD	3 Qtrs
Stock issued for cash, Minimum fair market value	`StockIssuedForCashMinimumFairMarketValue`	$0.01	USD	2 Qtrs
Stock issued for cash, Maximum fair market value	`StockIssuedForCashMaximumFairMarketValue`	$0.05	USD	2 Qtrs
Preferred stock issued for cash, Value per share	`PreferredStockIssuedForCashFairMarketValue`	$100.00	USD	3 Qtrs
Beginning balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$543.62K	USD	Point-in-time
Preferred stock issued for cash ($100/Share)	`PreferredStockIssuedDuringPeriodValueIssuedForCash`	$400.00K	USD	3 Qtrs
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$50.98K	USD	2 Qtrs
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$1.02M	USD	3 Qtrs
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Adjustments To Additional Paid In Capital Direct Offering Costs In Cash	`AdjustmentsToAdditionalPaidInCapitalDirectOfferingCostsInCash`	$110.19K	USD	13 Qtrs
Adjustments To Additional Paid In Capital Direct Offering Costs In Cash	`AdjustmentsToAdditionalPaidInCapitalDirectOfferingCostsInCash`	$110.19K	USD	3 Qtrs
Adjustments To Additional Paid In Capital Direct Offering Costs In Cash	`AdjustmentsToAdditionalPaidInCapitalDirectOfferingCostsInCash`	-	USD	3 Qtrs
Adjustments To Additional Paid In Capital Direct Offering Costs In Stock	`AdjustmentsToAdditionalPaidInCapitalDirectOfferingCostsInStock`	$-673.89K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-51.10K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.26K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.22M	USD	13 Qtrs
Net loss	`NetIncomeLoss`	$-8.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquity`	$543.62K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.